Real-world multicenter evidence on intranasal esketamine in treatment-resistant depression: from remission to recovery

Neuroscience Applied 2026 Open access

Read full text
Authors: Ana Isabel de Santiago-Díaz, S. Arostegui-Uranga, A. Pérez-Poza, C. Pavón-Navajas, J.E. Mesones-Peral, F. Mora-Mínguez, E. Sáez-Fuentes, M. Arrojo-Romero, L. Gutiérrez-Rojas, V. Tordera-Tordera, F.A. Rodríguez-Batista, I. Domingos-Chaves
+5 more D. Nuñez-Arias, V. Rosello-Molina, L. Montes-Reula, A. Miranda-Sivelo, M.A. Madrazo-Maza
DOI: 10.1016/j.nsa.2025.105666
Cited by: 0

Fields of Study & Subjects

Treatment of Major Depression Neurotransmitter Receptor Influence on Behavior Psychedelics and Drug Studies

Publication details

Journal / source
Neuroscience Applied
Volume
5
Pages
105666–105666
Publication date
1 January 2026
Language
EN